Trial Profile
A randomized, open label, parallel comparative study of efficacy and safety of duloxetine versus milnacipran in patients with fibromyalgia in a tertiary care centre
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2020
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary) ; Duloxetine
- Indications Fibromyalgia
- Focus Therapeutic Use
- 05 Jan 2018 New trial record